VBL Therapeutics Receives FDA Fast Track Designation for Ofra-Vec for the Treatment of Platinum-Resistant Ovarian Cancer
FDA grants Fast Track designation to facilitate development and expedite the review of therapies with…
FDA grants Fast Track designation to facilitate development and expedite the review of therapies with…
A Phase 1b clinical trial of ONC-392 in PD(L)1-resistant NSCLC is currently underway ROCKVILLE, Md.,…
Urges shareholders to vote “FOR” Athira’s highly qualified, independent director nominees – Joseph Edelman, John…
YARDLEY, Pa., April 26, 2022 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on…
DUBLIN, Ireland, April 26, 2022 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical…
Fireside chat scheduled for Thursday, April 28, 2022 at 12:30 PM ET NEW YORK, April…
Rebrand reflects an integrated approach to water safety, with expanded focus on customer solutions and educational…
Enhanced iSpecimen Marketplace Search Interface iSpecimen’s enhanced Marketplace now enables more precise specimen matching through…
SAN CARLOS, Calif., April 26, 2022 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a…
GAITHERSBURG, Md., April 26, 2022 (GLOBE NEWSWIRE) — NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company…
Company to host a webcast at 9:00am ET / 6:00am PT BURLINGAME, Calif., April 26,…
PORTLAND, Ore., April 26, 2022 (GLOBE NEWSWIRE) — Chalice Brands Ltd. (CSE: CHAL) (OTCQB: CHALF)…
Six in 10 of the women surveyed with depression or anxiety diagnosis say they have…
Mainz, Germany, April 26, 2022 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the…
MALVERN, Pa., April 26, 2022 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
PHILADELPHIA, April 26, 2022 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD) today announced that the…
WALTHAM, Mass., April 26, 2022 (GLOBE NEWSWIRE) — Apellis Pharmaceuticals, Inc. (Nasdaq: APLS), a global biopharmaceutical…
AUSTIN, Texas, April 26, 2022 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical company…
NEW HAVEN, Conn., April 26, 2022 (GLOBE NEWSWIRE) — BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a…
Sanofi teams up with McLaren Racing to accelerate industrial excellence Paris, April 26. Sanofi announces…